Dr.Zwart is a regulatory affairs professional specializing in the field of biologics at PAREXEL Consulting, UK. Isabel has experience in providing regulatory support and advice to Companies developing biologics and biosimilars. She has worked on products at all stages of development, providing input on manufacturing process issues, as well as clinical strategy for recombinant protein products. Isabel has been involved heavily in the field of biosimilar monoclonal antibodies, as well as biosimilars and biobetters of filgrastim. Prior to joining PAREXEL Dr. Zwart worked in regulatory affairs within a leading UK-based biopharmaceutical consultancy, specialising in biologics. She has also worked in conjunction with the National Health Service Blood and Transplant UK as part of the London Cord Blood Bank scheme, as well as spent time in industry in the manufacture of recombinant protein vaccines. Dr. Zwart holds a PhD in Clinical Medicine Research from Imperial College London working on stem cell therapies.